Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3027-3035

  Karachunski, Peter I ^a   Ostlie, Norma S ^a   Okita, David K ^a   Conti Fine, Bianca M ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholine receptor; Autoimmunity; Mice; Nasal tolerance; T cells

Indexed keywords

CHOLINERGIC RECEPTOR; EPITOPE;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031452406     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119857     Document Type: Article

References (49)

1. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
2. Nossal, G. 1995. Choices following antigen entry: antibody formation or immunologic tolerance? Annu. Rev. Immunol. 13:1-27.
3. Metzler, B., and D.C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5: 1159-1169.
4. Miller, A., O. Lider, O. Abramsky, and H.L. Weiner. 1994. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur. J. Immunol. 24:1026-1032.
5. Genain, C.P., K. Abel, N. Belmar, F. Villinger, D.P. Rosenberg, C. Linington, C.S. Raine, and S.L. Hauser. 1996. Late complications of immune deviation therapy in a nonhuman primate. Science. 274:2054-2057.
6. Al-Sabbagh, A., P. Nelson, Y. Akselband, R. Sobel, and H. Weiner. 1996. Antigen-driven peripheral immune tolerance - suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell. Immunol. 171:111-119.
7. Kuper, C. P. Koornstra, D. Hameleers, J. Biewenga, B.J. Spit, A.M. Duijvestijn, P.J. van Breda Vriesman, and T. Sminia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today. 13:219-224.
8. Liu, L., and G.G. MacPherson. 1993 Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177:1299-1307.
9. Husby, S., J. Mestecky, Z. Moldoveanu, S. Holland, and C. Elson. 1994. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:4663-4670.
10. Neutra, M., E. Pringult, and J. Kraehenbuhl. 1996. Antigen sampling across epithelial barriers and induction of mucosal immune response. Ann. Rev. Immunol. 14:275-300.
11. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
12. Conti-Fine, B.M, K.E. McLane, and S. Lei. 1996. Antibodies as a tool to study the structure of membrane proteins. The case of the nicotinic receptor. Annu. Rev. Biophys. Biomol. Struct. 25:197-229.
13. Karpus, W.J., K.J. Kennedy, W.S. Smith, and S.D. Miller. 1996. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP 139-151 peptide. Neurosci. Res. 45:410-423.
14. Dick, A., Y. Cheng, A. McKinnon, J. Liversidge, and J. Forrester. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Brit. J. Ophthalmol. 77:171-175.
15. Ma, C., G. Zhang, B. Xiao, J. Link, T. Olsson, and H. Link. 1995. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58:51-60.
16. Ma, C., G. Zhang, B. Xiao, and H. Link. 1996. Cellular mRNA of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). Clin. Exp. Immunol. 104:509-516.
17. Ma, C., G. Zhang, B. Xiao, Z.Y. Wang, J. Link, T. Olsson, and H. Link. 1996. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ann. N.Y. Acad. Sci. 778:273-287.
18. Conti-Fine, B.M., M.P. Protti, M. Bellone, and J.F. Howard, Jr. 1997. Myasthenia Gravis: The Immunobiology of an Autoimmune Disease. R.G. Landes Company, Austin, Texas. 230 pp.
19. Houghten, R. 1985. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA. 82:5131-5135.
20. Raju, R., D. Navaneetham, D. Okita, B. Diethelm-Okita, D. McCormick, and B. Conti-Fine. 1995. Epitopes for human CD41 cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects. Eur. J. Immunol. 25:3207-3214.
21. Bellone, M., N. Ostlie, S. Lei, and B. Conti-Tronconi. 1991. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the a subunits of Torpedo californica and murine acctylcholine receptors. Eur. J. Immunol. 21:2303-2310.
22. Schmidt, J., and M. Raftery. 1973. A simple assay for the study of solubilized acetylcholine receptors. Anal. Biochem. 52:349-354.
23. Lowry, O., N. Rosebrough, A. Farr, and R. Randall. 1981. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:256.
24. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
25. Karachunski, P., N. Ostlie, M. Bellone, A. Infante, and B. Conti-Fine. 1995. Mechanisms by which the I-Abm12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Scand. J. Immunol. 42:215-225.
26. DeSilva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
27. Palmer, M., and E. Sercarz, 1989. Determinant preferences in the relationship between T and B cell specific for lysozyme. In The Immune Response to Structurally Defined Proteins: The Lysozyme Model. S. Smith-Gill, and E. Sercarz, editors. Academic Press, New York. 285-321.
28. Myers, C.D. 1991. Role of B cell antigen processing and presentation in the humoral immune response. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:2547-2553.
29. Bellone, M., P. Karachunski, N. Ostlie, S. Lei, and B. Conti-Tronconi. 1994. Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur. J. Immunol. 24:799-804.
30. Shenoy, M., M. Oshima, M. Atassi, and P. Christadoss. 1993. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:230-238.
31. Shenoy, M., E. Goluszko, and P. Christadoss. 1994. The pathogenic role of acetylcholine receptor a chain epitope with in a146-162 in the development of experimental autoimmune myasthenia gravis in C57B1/6 mice. Clin. Immunol. Immunopathol. 73:1-6.
32. Bellone, M., N. Ostlie, S. Lei, X.-D. Wu, and B. Conti-Tronconi. 1991. The I-A bm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD41 cells sensitized to nicotinic acetylcholine receptor. J. Immunol. 147:1484-1491.
33. Infante, A., P. Thompson, K. Krolik, and K. Wall. 1991. Determinant selection in murine experimental autoimmune myasthenia gravis: effect of the bm12 mutation on T-cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:2977-2982.
34. Yeh, T.M., and K.A. Krolick. 1990. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. J. Immunol. 144:1654-1660.
35. Conti-Fine, B.M., B. Diethelm-Okita, P. Karachunski, J. Howard, Jr., D. Okita, D. Navanitham, R. Raju, and Z.-Y. Wang. 1997. T-cell recognition of the Acetylcholine receptor in myasthenia gravis. Ann. N. Y. Acad. Sci. In press.
36. Weiner, H., A. Friedman, A. Miller, S.J. Khoury, A. Al-Sabbagh, L. Santos, M. Sayegh, R.B. Nussenblatt, D.E. Trenthan, and A.D. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809-837.
37. Chen, Y., J. Inobe, R. Marks, P. Gonnella, V. Kuchroo, and H. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 376:177-180.
38. Chen, Y., J. Inobe, V. Kuchroo, J. Baron, C.J. Janeway, and H. Weiner. 1996. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA. 93:388-391.
39. Friedman, A., and H.L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:6688-6692.
40. Gregerson, D., W. Obritsch, and L. Donoso. 1993. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs. high dose feeding protocols. J. Immunol. 151:5751-5761.
41. Bellone, M., N. Ostlie, P. Karachunski, A. Manfredi, and B. Conti-Tronconi. 1993. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD41 cells. J. Immunol. 151:1025-1038.
42. McRae, B., C. Vanderlugt, M. Dal Canto, and S. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
43. Yu, M., J. Johnson, and V. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
44. Wang, Z.-Y., D. Okita, J. Howard, Jr., and B. Conti-Fine. 1997. TH1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in Myasthenia Gravis. Neurology. 48:1643-1653.
45. Chen, Y., V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1237-1240.
46. Gray, D. 1993. Immunological memory. Annu. Rev. Immunol. 11:49-77.
47. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class H and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
48. Ho, P., D. Mutch, K. Winkel, A.J. Saul, G.L. Jones, T.J. Doran, and C.M. Rzepczyk. 1990. Identification of two promiscuous T cell epitopes from tetanus toxin. Eur. J. Immunol. 20:477-483.
49. Diethelem-Okita, B., R. Raju, D. Okita, and B. Conti-Fine. 1997. Epitope repertoire of human CD41 T cells on tetanus toxin: identification of immunodominant sequence segments. J. Infect. Dis. 175:382-391.